🎉 M&A multiples are live!
Check it out!

Julphar Valuation Multiples

Discover revenue and EBITDA valuation multiples for Julphar and similar public comparables like Protalix, Vivoryon Therapeutics, and Galapagos.

Julphar Overview

About Julphar

Gulf Pharmaceutical Industries PSC is in the business of manufacturing and selling medicines, drugs, and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The company operates in four segments: Manufacturing, Planet, Investments, and others. The majority of its revenue is generated from the planet segment. The geographical segments are UAE, Other GCC countries, and Other countries.


Founded

1980

HQ

United Arab Emirates
Employees

2.3K+

Website

julphar.net

Financials

LTM Revenue $365M

LTM EBITDA $49.8M

EV

$618M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Julphar Financials

Julphar has a last 12-month revenue of $365M and a last 12-month EBITDA of $49.8M.

In the most recent fiscal year, Julphar achieved revenue of $446M and an EBITDA of $31.3M.

Julphar expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Julphar valuation multiples based on analyst estimates

Julphar P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $440M $446M XXX XXX XXX
Gross Profit $104M $136M XXX XXX XXX
Gross Margin 24% 30% XXX XXX XXX
EBITDA $40.3M $31.3M XXX XXX XXX
EBITDA Margin 9% 7% XXX XXX XXX
Net Profit $17.5M -$8.0M XXX XXX XXX
Net Margin 4% -2% XXX XXX XXX
Net Debt $152M $185M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Julphar Stock Performance

As of April 15, 2025, Julphar's stock price is AED 1 (or $0).

Julphar has current market cap of AED 1.4B (or $377M), and EV of AED 2.3B (or $618M).

See Julphar trading valuation data

Julphar Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$618M $377M XXX XXX XXX XXX $0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Julphar Valuation Multiples

As of April 15, 2025, Julphar has market cap of $377M and EV of $618M.

Julphar's trades at 1.7x LTM EV/Revenue multiple, and 12.4x LTM EBITDA.

Analysts estimate Julphar's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Julphar and 10K+ public comps

Julphar Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $618M XXX XXX XXX
EV/Revenue 1.4x XXX XXX XXX
EV/EBITDA 19.8x XXX XXX XXX
P/E -14.0x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 34.8x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Julphar Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Julphar Valuation Multiples

Julphar's NTM/LTM revenue growth is 8%

Julphar's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Julphar's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Julphar's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Julphar and other 10K+ public comps

Julphar Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 1% XXX XXX XXX XXX
EBITDA Margin 7% XXX XXX XXX XXX
EBITDA Growth -22% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 15% XXX XXX XXX XXX
Revenue per Employee $0.2M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue 8% XXX XXX XXX XXX
G&A Expenses to Revenue 3% XXX XXX XXX XXX
R&D Expenses to Revenue 1% XXX XXX XXX XXX
Opex to Revenue 36% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Julphar Public Comps

See public comps and valuation multiples for Biopharmaceuticals and Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
Armata Pharmaceuticals XXX XXX XXX XXX XXX XXX
Protalix XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Julphar M&A and Investment Activity

Julphar acquired  XXX companies to date.

Last acquisition by Julphar was  XXXXXXXX, XXXXX XXXXX XXXXXX . Julphar acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Julphar

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Julphar

When was Julphar founded? Julphar was founded in 1980.
Where is Julphar headquartered? Julphar is headquartered in United Arab Emirates.
How many employees does Julphar have? As of today, Julphar has 2.3K+ employees.
Is Julphar publicy listed? Yes, Julphar is a public company listed on ADS.
What is the stock symbol of Julphar? Julphar trades under JULPHAR ticker.
When did Julphar go public? Julphar went public in 2002.
Who are competitors of Julphar? Similar companies to Julphar include e.g. Galapagos, Pharming, Vivoryon Therapeutics, Armata Pharmaceuticals.
What is the current market cap of Julphar? Julphar's current market cap is $377M
What is the current revenue of Julphar? Julphar's last 12-month revenue is $365M.
What is the current EBITDA of Julphar? Julphar's last 12-month EBITDA is $49.8M.
What is the current EV/Revenue multiple of Julphar? Current revenue multiple of Julphar is 1.7x.
What is the current EV/EBITDA multiple of Julphar? Current EBITDA multiple of Julphar is 12.4x.
What is the current revenue growth of Julphar? Julphar revenue growth between 2023 and 2024 was 1%.
Is Julphar profitable? Yes, Julphar is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.